TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 2 | 3 | -1 | -10 | -24 | 21 | -27 | -6 |
| S | %wins | 0 | 50 | 100 | 100 | 0 | 100 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/15 19:09 | 3/2/15 | ARDX | Ardelyx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jue George | CA | O | VP,Opera | S | -24 | 15.88 | 2 | -2 | -2 | 98 | D | 3 | -42 | -39 | -2 | -10 | -4 | 3 | -2 | -15 | -32 | 22 | -33 | ||
11/16/06 16:25 | 11/8/06 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jue George | CA | O | VP of Fi | M.d | 145 | 15.73 | 33 | 9 | 434 | 11 | D | 16 | -14 | 17 | 21 | 10 | 7 | 8 | 6 | 2 | 1 | -4 | -15 | 19 | -20 |
11/16/06 16:25 | 11/8/06 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jue George | CA | O | VP of Fi | S.d | -199 | 21.58 | 33 | -9 | -45 | 11 | D | 16 | -14 | 17 | 21 | 10 | 7 | 8 | 6 | 2 | 1 | -4 | -15 | 19 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |